NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX:
Post# of 87
Canopy Rivers (TSX: RIV) (OTC: CNPOF) portfolio company BioLumic Ltd. has received New Zealand Ministry of Health approval to apply its proprietary ultraviolet (“UV”) light technology to medical cannabis. According to the update, BioLumic’s approach has been successful in increasing yields in certain crops, such as strawberries, by up to 60%. This approval marks the first time the company’s UV light technology will be used on cannabis, which BioLumic hopes will show increased yields and help producers meet the rising demand for medical cannabis and cannabis-derived products. “The partnership between BioLumic and JWC is another sign of strong collaboration in the Canopy Rivers ecosystem,” Canopy Rivers President and CEO Narbé Alexandrian said in the news release. “We expect that BioLumic’s expertise in non-cannabis agriculture technology will help cannabis cultivators like JWC produce high-yield, sustainable strains that meet consumer demands and patient needs.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer